Pharma Mar, S.A.
PHMMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2 | $1 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -25.8% | 45.1% | -19.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 87.9% | 95.1% | 91.2% | 97.3% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -5.5% | 46.4% | -2.8% | 31.4% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | -11.5% | 41.4% | -10.2% | 38.6% |
| EPS Diluted | -0.28 | 1.35 | -0.23 | 1.06 |
| % Growth | -120.7% | 687% | -121.7% | – |
| Operating Cash Flow | $0 | $0 | -$0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |